Irvine, CA, United States of America

Maxime Cannesson

This inventor holds 9 USPTO granted patents and 5 published patent applications. Top assignees: University of California, Sironis, Inc.. Active years: 2013-2026.

USPTO Granted Patents = 9 

% Patents Active = 88.9

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Maxime Cannesson: Innovator in Hemodynamic Management

Introduction

Maxime Cannesson is a prominent inventor based in Irvine, California. He has made significant contributions to the field of hemodynamic management, holding a total of eight patents. His work focuses on developing systems and methods that enhance patient care through innovative technology.

Latest Patents

One of Cannesson's latest patents is a system and method for closed-loop patient-adaptive hemodynamic management. This invention describes a system that includes transfusion, volume resuscitation with intravenous fluids, and medications. It utilizes monitored hemodynamic parameters, including dynamic predictors of fluid responsiveness. The system features an intelligent algorithm capable of adapting the device's function to meet the specific needs of individual patients.

Career Highlights

Throughout his career, Maxime Cannesson has worked with esteemed organizations such as the University of California and Sironis, Inc. His experience in these institutions has allowed him to refine his expertise in hemodynamic management and contribute to advancements in medical technology.

Collaborations

One of Cannesson's notable collaborators is Joseph B. Rinehart. Their partnership has likely fostered innovative ideas and solutions in the realm of patient care.

Conclusion

Maxime Cannesson's work in hemodynamic management exemplifies the impact of innovation in healthcare. His patents and collaborations continue to shape the future of patient-adaptive technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…